title: BCR-ABL antisense purging in chronic myeloid leukaemia.
authors.forename: M A
authors.initials: MA
authors.lastname: Kirkland
authors.forename: S G
authors.initials: SG
authors.lastname: O'Brien
authors.forename: C
authors.initials: C
authors.lastname: McDonald
authors.forename: R J
authors.initials: RJ
authors.lastname: Davidson
authors.forename: N C
authors.initials: NC
authors.lastname: Cross
authors.forename: J M
authors.initials: JM
authors.lastname: Goldman
mesh_terms: D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000378:metabolism; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology / Q000628:therapy*; D016376:Oligonucleotides, Antisense / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000473:pathology
chemical_list: D016376:Oligonucleotides, Antisense; D016178:Granulocyte-Macrophage Colony-Stimulating Factor